Head of Global Marketing Strategy – Efdoralprin Alpha; AATD

Head of Global Marketing Strategy — Efdoralprin Alpha (AATD)

Location:

Cambridge, MA

The Head of Global Marketing Strategy for Efdoralprin Alpha will be responsible for the successful launch and long‑term success of the brand in the Rare Diseases Franchise, with a focus on alpha‑1 antitrypsin deficiency (AATD). This role will act as Chief Marketing Officer of the brand and will lead a senior‑level, cross‑functional Global Brand Team. The scope of the role includes Global pre‑launch, launch and post‑launch phases.

Responsibilities entail developing comprehensive Global pre‑launch and launch plans and ensuring excellence in launch execution. The role requires advanced strategic agility, cross‑functional leadership, executive communication skills and enterprise networking. Global and US launch experience, and a background in Rare Disease and Respiratory, are critical. Additional responsibilities include navigating the challenging access and pricing environment and shaping the regulatory approval process, all with a strong focus on compliance.

The potential therapy has blockbuster commercial potential, and we are looking for an exceptional leader with a proven track record of building blockbuster brands. The position reports to the Global TA Head Rare Disease Launches and is based in Cambridge, Massachusetts.

• Global Brand Leadership and Strategy — Lead the Global Brand Team (GBT), responsible for the development of brand strategy and ensuring consistent global execution. GBT is comprised of senior leaders from key markets and functions, including Commercial, Medical, Regulatory, Development, Legal, M&S and Supply Chain.
• Commercial Chair on Global Product Team (GPT) — GPT serves as the central cross‑functional governance body responsible for strategic oversight and coordination of a product’s development journey from early‑stage research through commercialization. Chaired by Product Development leadership, this team integrates expertise across R&D, commercial, medical, regulatory, manufacturing and other critical functions to ensure aligned decision‑making and seamless execution of the product strategy.
• Develop the commercial ambition for the brand — Define short, mid and long‑term commercial ambitions and deploy strategies to achieve business goals; act as the primary internal “champion” for Efdoralprin Alpha and represent the brand in presentations to senior management.
• Partner with Global Medical and HEVA on the development of a Scientific Key Message platform — Provide input into Scientific Communications planning for publication strategy and brand awareness generation.
• Partner with Global Market Research — Ensure robust execution of launch foundation insight generation, including a demand study, competitive TPP, market map, HCP and patient segmentation, treatment journey, patient journey (diagnosis and treatment), HCP needs and drivers, patient needs and drivers.
• Partner with New Product Planning — Develop the Therapeutic Area Strategy Narrative and support brand Life‑Cycle Management (LCM) development.
• Articulate a clear brand strategy — Create a brand narrative and align the organization around it.
• Launch Capabilities and Execution — In partnership with Wave 1 launch markets and Global Rare Commercialization Team, lead the creation of launch business cases, identify the ideal market shaping plan, work with countries and Medical Affairs to execute it and measure effectiveness through pre‑determined KPIs; incorporate Efdoralprin Alpha strategies with the Sanofi Integrated Launch Capabilities (SILC) to enable launch simulation and scenario planning;
  
  lead preparation for launch and ensure all elements of the plan are designed, high quality and executed with precision; develop a diagnosis and patient find strategy with Global Rare Disease Patient Activation; develop a multichannel strategy/approach to amplify the Efdoralprin Alpha experience with GTMC (Go To Market Capabilities) Omnichannel.
• Performance Management and Business Operations — Achieve sales, profit and market share within agreed budgets; monitor and review business performance and ensure management actions…